MassBio Hosts Regulatory Roundtable with BIO
This week, MassBio and the Biotechnology Industry Organization (BIO) convened a group of regulatory experts in Massachusetts to discuss a new U.S. Food and Drug Administration (FDA) Survey Initiative. BIO will be
launching a FDA Continuous Journal Survey later this year to allow company regulatory teams the opportunity to provide input on how they view their interactions with the FDA. Tuesday’s meeting brought together regulatory experts from seven Massachusetts life science companies to discuss the formulation of the survey.